198 related articles for article (PubMed ID: 21390327)
21. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
[TBL] [Abstract][Full Text] [Related]
22. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.
Kim MS; Yoon SK; Bollig F; Kitagaki J; Hur W; Whye NJ; Wu YP; Rivera MN; Park JY; Kim HS; Malik K; Bell DW; Englert C; Perantoni AO; Lee SB
J Biol Chem; 2010 May; 285(19):14585-93. PubMed ID: 20220130
[TBL] [Abstract][Full Text] [Related]
23. The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions.
Dougherty GW; Chopp T; Qi SM; Cutler ML
Exp Cell Res; 2005 May; 306(1):168-79. PubMed ID: 15878342
[TBL] [Abstract][Full Text] [Related]
24. The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b).
Wagner KD; Wagner N; Schley G; Theres H; Scholz H
Gene; 2003 Feb; 305(2):217-23. PubMed ID: 12609742
[TBL] [Abstract][Full Text] [Related]
25. PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions.
Braun A; Bordoy R; Stanchi F; Moser M; Kostka G G; Ehler E; Brandau O; Fässler R
Exp Cell Res; 2003 Apr; 284(2):239-50. PubMed ID: 12651156
[TBL] [Abstract][Full Text] [Related]
26. Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms' tumor 1 (WT1).
Tsotakos NE; Sagnou M; Kotsopoulou ES; Tsilibary EC; Drossopoulou GI
BMC Cell Biol; 2013 Jun; 14():28. PubMed ID: 23768159
[TBL] [Abstract][Full Text] [Related]
27. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
Lee TH; Moffett P; Pelletier J
Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
[TBL] [Abstract][Full Text] [Related]
28. The miR-143/145 cluster induced by TGF-β1 suppresses Wilms' tumor 1 expression in cultured human podocytes.
Tabei A; Sakairi T; Hamatani H; Ohishi Y; Watanabe M; Nakasatomi M; Ikeuchi H; Kaneko Y; Kopp JB; Hiromura K
Am J Physiol Renal Physiol; 2023 Jul; 325(1):F121-F133. PubMed ID: 37167274
[TBL] [Abstract][Full Text] [Related]
29. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.
Johnstone RW; See RH; Sells SF; Wang J; Muthukkumar S; Englert C; Haber DA; Licht JD; Sugrue SP; Roberts T; Rangnekar VM; Shi Y
Mol Cell Biol; 1996 Dec; 16(12):6945-56. PubMed ID: 8943350
[TBL] [Abstract][Full Text] [Related]
30. Rsu1 contributes to cell adhesion and spreading in MCF10A cells via effects on P38 map kinase signaling.
Kim YC; Gonzalez-Nieves R; Cutler ML
Cell Adh Migr; 2015; 9(3):227-32. PubMed ID: 25482629
[TBL] [Abstract][Full Text] [Related]
31. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis.
Guo JK; Menke AL; Gubler MC; Clarke AR; Harrison D; Hammes A; Hastie ND; Schedl A
Hum Mol Genet; 2002 Mar; 11(6):651-9. PubMed ID: 11912180
[TBL] [Abstract][Full Text] [Related]
32. Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1.
Zhang Y; Xu C; Ye Q; Tong L; Jiang H; Zhu X; Huang L; Lin W; Fu H; Wang J; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2021 May; 232(1):e13634. PubMed ID: 33615732
[TBL] [Abstract][Full Text] [Related]
33. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein.
Madden SL; Cook DM; Rauscher FJ
Oncogene; 1993 Jul; 8(7):1713-20. PubMed ID: 8510918
[TBL] [Abstract][Full Text] [Related]
34. The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53.
Stanhope-Baker P; Kessler PM; Li W; Agarwal ML; Williams BR
J Biol Chem; 2004 Aug; 279(32):33575-85. PubMed ID: 15155752
[TBL] [Abstract][Full Text] [Related]
35. Plekhh2, a novel podocyte protein downregulated in human focal segmental glomerulosclerosis, is involved in matrix adhesion and actin dynamics.
Perisic L; Lal M; Hulkko J; Hultenby K; Önfelt B; Sun Y; Dunér F; Patrakka J; Betsholtz C; Uhlen M; Brismar H; Tryggvason K; Wernerson A; Pikkarainen T
Kidney Int; 2012 Nov; 82(10):1071-83. PubMed ID: 22832517
[TBL] [Abstract][Full Text] [Related]
36. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1.
Carpenter B; Hill KJ; Charalambous M; Wagner KJ; Lahiri D; James DI; Andersen JS; Schumacher V; Royer-Pokora B; Mann M; Ward A; Roberts SG
Mol Cell Biol; 2004 Jan; 24(2):537-49. PubMed ID: 14701728
[TBL] [Abstract][Full Text] [Related]
37. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
Jing Z; Wei-jie Y; Yi-Feng ZG
Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
[TBL] [Abstract][Full Text] [Related]
39. Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in Xenopus.
White JT; Zhang B; Cerqueira DM; Tran U; Wessely O
Development; 2010 Jun; 137(11):1863-73. PubMed ID: 20431116
[TBL] [Abstract][Full Text] [Related]
40. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]